Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7820 plus Irinotecan vs FOLFIRI in 2nd-line Colorectal Cancer
NCT01347645Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of e7820 in colorectal adenocarcinoma, sponsored by Eisai Co., Ltd.. Started Sep 2011; status: terminated.
02
Drugs
e7820
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT01347645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347645.